Indian Pharma News - Latest Updates & Headlines
Indian pharma market to grow 8-9 per cent in FY26: Report
New Delhi, March 10: Indian pharmaceuticals market is expected to grow 8-9 per cent year-on-year in FY26, according to a report on Monday.
US tariffs will have minimal impact on Indian pharma service companies like CDMOs: Report
New Delhi, March 10: Indian pharma companies like CDMOs (Contract Development and Manufacturing Organizations) will not see major disruptions from the proposed US tariffs of 10-25 per cent, according to a report by B&K Securities.
Pharma sector in focus at India-Vietnam business meet in Ho Chi Minh City
Ho Chi Minh, Mar 3: As many as 39 Indian pharma companies connected with more than 50 Vietnamese counterparts, holding productive discussions during an 'India-Vietnam Business-to-Business (B2B)' meeting on the pharmaceutical industry organised in Vietnam's Ho Chi Minh City on Monday.
Indian pharma sector sees growth at 8 pc CAGR, export rates spike by 9 pc in 2024: Report
New Delhi, Feb 28: The Indian pharma sector has grown at 8 per cent CAGR and has also seen a 9 per cent increase in export rates in 2024, according to a report.
Indian CRDMO sector set to touch USD 22-25 billion by 2035: Report
New Delhi, February 25: The Indian Contract Research, Development, and Manufacturing Organization (CRDMO) sector is expected to touch USD 22 billion to USD 25 billion by 2035, according to a report by the Boston Consulting Group (BCG) and Innovative Pharmaceutical Services Organization (IPSO).
India's CDMO market set to double by 2028 amid Asia's healthcare boom
New Delhi, February 9: India's Contract Development and Manufacturing Organization (CDMO) market is poised for exponential growth, expected to expand from USD 7 billion to USD 14 billion by 2028, capturing 4-5 per cent of the global market, according to BCG report.
India reaffirms commitment to global Pharmaceutical standards at the 15th IMWP
New Delhi, February 5: Union Minister of State for Health and Family Welfare, Anupriya Patel, delivered the keynote address at the 15th International Meeting of World Pharmacopoeias (IMWP), hosted by the Indian Pharmacopoeia Commission (IPC) under the Ministry of Health and Family Welfare, Government of India, in collaboration with the World Health Organisation (WHO), on Wednesday, according to the official statement.
Budget 2025: India Pharmaceutical Alliance welcomes exemptions, concessions on essential drugs
By Shalini Bhardwaj, New Delhi, February 1: The Indian Pharmaceutical Alliance (IPA) has welcomed the Union Budget 2025, emphasising the government's 'commitment' towards sustainable and equitable healthcare through targeted reforms.
'Extremely grateful for recognition': Zydus Lifesciences Chairman elated over Padma Bhushan honour
New Delhi, Jan 26: Chairman of Zydus Lifesciences, Pankaj Patel, on Sunday thanked the Government for bestowing Padma Bhushan upon him, and said he was “extremely grateful for the recognition”.
Indian Pharma Industry to see negative volume growth in 3Q 2025, but will maintain strong gross margins: Report
New Delhi, January 13: The Indian pharmaceutical market (IPM) has returned to negative volume growth this Q3FY25 after two consecutive quarters of modest positive growth, according to Goldman Sachs report.
Robust earnings growth to continue in healthcare sector in Q3FY25: Report
New Delhi, January 7: Pharma companies in India are expected to report healthy earnings growth in the just-concluded October-December quarter, averaging 19.4 per cent, as per a report by brokerage firm Motilal Oswal.